Baltimore, Maryland
Julius H. Jacobson II, Professor of Surgery
The Johns Hopkins University School of Medicine
Vice Chair Clinical Operations Emeritus, Dept. of Surgery; Chief Emeritus Div. Vasc Surg
The Johns Hopkins Hospital
SCHEDULE FOR VEITHsymposium™
Tuesday, November 14, 2023
Session Moderator
SESSION-10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
Presenter
SESSION 10: NEW DEVELOPMENTS IN CAROTID DISEASE AND ITS TREATMENT; DIFFERING VIEWS ON TREATMENT OF ASYMPTOMATIC CAROTID STENOSIS (ACS) AND CAROTID SCREENING
DEBATE: Not So: About 25% Of ACS Patients Can Benefit From CEA Or CAS And Should Be So Treated And Reimbursed Accordingly
8:32 AM - 8:37 AM
Wednesday, November 15, 2023
Presenter
SESSION 38: UPDATES AND ISSUES IMPORTANT TO ALL VASCULAR SURGEONS AND SPECIALISTS: FUTURE REIMBURSEMENT; VASCULAR REGISTRIES AND THE VQI, VALUE OF GUIDELINES AND RCTS: THE FDA: STAISTICS; EVIDENCE BASED MEDICINE; MISCELLANEOUS
Despite What The New York Times And Others Say, Close Relationships Of Vascular Surgeons With Industry Are Mostly Ethical And Beneficial To Patients And Society: Pitfalls To Avoid
5:51 PM - 5:56 PM
Friday, November 17, 2023
Presenter
SESSION 80: NEW DEVELOPMENTS IN THE TREATMENT OF CAROTID STENOSIS WITH MESH COVERED STENTS AND TCAR (TRANSCERVICAL CAROTID ARTERY REVASCULARIZATION)
DEBATE: Not So Fast: TCAR Is Not Yet Ready To Replace CEA Widely: We Still Need Further Proof And More Studies Possibly Including An RCT
8:35 AM - 8:40 AM
 
previous next